Author: Nichols Martin|| Date Published: July 8, 2020
Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.
The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.
Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.
ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.
eSimplicity announced on LinkedIn Tuesday that Richard Smith has been appointed vice president and general manager of defense and national security. What…
The Department of Veterans Affairs has issued a presolicitation for the Veterans Health Administration’s Biomedical Engineering Technical Professional Support Services, or…
Trident Solutions has acquired space electronics developer Ibeos, expanding its capabilities in on-orbit computing and power systems used in government…